Hetero Labs is instructed by the CDSCO panel to conduct a bioequivalence study on Elagolix tablets.

Published Date: 17 Jul 2023

New Delhi: In response to the proposal made by the major pharmaceutical company Hetero Labs to produce and sell Elagolix tablets in 150mg and 200mg, the subject.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Psychedelic Therapy Tied to Reduced Depression, Anxiety.

2.

Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer

3.

Taking vitamin D daily decreased cancer mortality, according to a study.

4.

Study reveals increase in late-stage breast cancer diagnoses in US

5.

Prostate cancer Q&A: Improving detection and reducing overtreatment


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot